Mini Review - Archives of General Internal Medicine (2024) Volume 8, Issue 3
Innate vs. Adaptive Immunity: Bridging the Gap in Immunological Understanding
Verek Jilroy *
Department of Medicine, London University, United Kingdom
- *Corresponding Author:
- Verek Jilroy
Department of Medicine, London University, United Kingdom
E-mail: v.jilroy@ucl.ac.uk
Received: 29-May-2024, Manuscript No. AAAGIM-24-136831; Editor assigned: 31-May-2024, PreQC No. AAAGIM-24-136831 (PQ); Reviewed: 14-Jun-2024, QC No. AAAGIM-24-136831; Revised: 17-Jun-2024, Manuscript No. AAAGIM-24-136831(R); Published: 24-Jun-2024, DOI:10.35841/aaagim-8.3.235
Citation: : Jilroy V. Innate vs. adaptive immunity: Bridging the gap in immunological understanding. Arch Gen Intern Med. 2024;8(3):235.
Introduction
The immune system is an intricate network of cells, tissues, and organs that work together to defend the body against harmful pathogens such as bacteria, viruses, fungi, and parasites. To effectively protect the body, the immune system employs two main strategies: innate immunity and adaptive immunity. While these two arms of the immune system have distinct roles and mechanisms, their interplay is crucial for a comprehensive and effective immune response. Understanding the differences and connections between innate and adaptive immunity is key to advancing immunological research and improving therapeutic strategies [1, 2].
Innate immunity represents the body's initial and immediate response to invading pathogens. It is non-specific, meaning it does not target specific pathogens but rather recognizes and responds to general features common to many pathogens. Key components of the innate immune system include physical barriers, such as the skin and mucous membranes, and a variety of immune cells and molecules. The skin acts as a physical barrier, preventing the entry of pathogens. Mucous membranes lining the respiratory, gastrointestinal, and urogenital tracts trap pathogens. Additionally, chemical barriers like stomach acid and enzymes in saliva and tears can neutralize invaders. Macrophages, neutrophils, and dendritic cells are phagocytes that engulf and digest pathogens. These cells also play a role in alerting the adaptive immune system by presenting pathogen-derived antigens on their surface [3, 4].
NK cells target and destroy infected or abnormal cells, such as cancer cells, by recognizing stress signals and other markers on these cells. PRRs, such as Toll-Like Receptors (TLRs), recognize Pathogen-Associated Molecular Patterns (PAMPs) found on many pathogens. This recognition triggers an immediate immune response. When tissues are damaged or infected, an inflammatory response is initiated. This involves the release of signaling molecules like cytokines and chemokines, which attract immune cells to the site of infection and promote healing [5, 6].
Adaptive immunity, also known as acquired immunity, is characterized by its ability to recognize and remember specific pathogens. This specificity is achieved through the generation of diverse receptors on B and T lymphocytes, allowing the immune system to target unique antigens. Adaptive immunity takes longer to initiate compared to innate immunity but provides a more targeted and effective response. B cells are responsible for the humoral immune response. Upon encountering their specific antigen, B cells can differentiate into plasma cells, which produce antibodies. These antibodies neutralize pathogens and mark them for destruction by other immune cells. T cells are central to the cell-mediated immune response. There are several subsets of T cells, including helper T cells (Th cells), which coordinate the immune response by releasing cytokines, and cytotoxic T cells (Tc cells), which kill infected or abnormal cells [7, 8].
Dendritic cells and other Antigen-Presenting Cells (APCs) process and present antigens to T cells, initiating the adaptive immune response. This interaction is crucial for the activation and differentiation of T cells. After an initial immune response, some B and T cells differentiate into memory cells. These cells persist in the body and provide a rapid and robust response upon re-exposure to the same pathogen, forming the basis of immunological memory. While innate and adaptive immunity have distinct characteristics, they are not isolated systems. Instead, they interact and complement each other to ensure a coordinated and effective immune response. Several mechanisms illustrate the bridge between these two arms of the immune system. Innate immune cells, such as dendritic cells, play a critical role in bridging innate and adaptive immunity. By capturing antigens and presenting them to T cells, these cells link the initial innate response to the more specialized adaptive response [9, 10].
Conclusion
Innate and adaptive immunity are fundamental components of the immune system, each with unique roles and mechanisms. Their interplay is essential for a comprehensive and effective immune response. By bridging the gap between these two arms of immunity, researchers and clinicians can develop better strategies to prevent and treat a wide range of diseases. Continued research into the connections between innate and adaptive immunity will undoubtedly lead to further advancements in immunological understanding and therapeutic innovation.
References
- Fujii S, Miura Y. Immunomodulatory and regenerative effects of MSC-derived extracellular vesicles to treat acute GVHD. Stem Cells. 2022;40(11):977-90.
- Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018(8):493-507.
- Bonoldi VL, Yoshinari NH, Aniz PA, et al. Innate and Th1/Th17 adaptive immunity in acute and convalescent Brazilian borreliosis disease. Braz J Infect Dis. 2021;25:101575.
- Dell’Oste V, Biolatti M, Galitska G, et al. Tuning the orchestra: HCMV vs. innate immunity. Front Microbio. 2020;11:507386.
- Mitsialis V, Wall S, Liu P, et al. Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn’s disease. Gastroenterology. 2020;159(2):591-608.
- Simbrunner B, Hartl L, Jachs M, et al. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis. JHEP Rep. 2023;5(5):100712.
- Kerboua KE. The perplexing question of trained immunity vs adaptive memory in COVID?19. J Med Virol. 2020;92(10):1858-63.
- Gozgit JM, Vasbinder MM, Abo RP, et al. PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity. Cancer Cell. 2021;39(9):1214-26.
- Chow LK, Chung DL, Tao L, et al. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma. EBioMedicine. 2022;86.
- Morandi F, Yazdanifar M, Cocco C, et al. Engineering the bridge between innate and adaptive immunity for cancer immunotherapy: focus on γδ T and NK cells. Cells. 2020;9(8):1757.
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref